How to navigate EU MAA Regulations and Registration Regulatory legislation in China differs substantially from that of the European Union. For Chinese biotech companies looking to enter this market it is critical to ass...
Making sense of the rapidly changing biosimilars landscape
Strategies for adapting and achieving optimal market access
Read the whitepaperBuilding a comparative evidence base using network meta-analysis
Methods, implementation and reporting
Read the whitepaperDownload Global and China biotech survey reports
Two new survey reports of 260+ Global and China-based biotech leaders are ready to download
Get your copy nowFrom bottlenecks to breakthroughs
Human-centred strategies for faster study starts
Read the whitepaper
Featured solutions
EngageAI
Our voice of the customer feedback platform has been enhanced using AI; transforming how we listen, respond, and act on your feedback.
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
Obesity
ICON has the cross functional expertise to help sponsors overcome the challenges associated with obesity research.
Webinars
Panel discussion: Flow cytometry in bioanalysis
26 March 2026. Register today.
ICH GCP E6(R3): Preparing for global implementation, assessing the impact, risk and requirements of the change
Watch the webinar.
Riding the data wave: How pharma can navigate disruptions in open claims
Watch the webinar.
